For instance, in syngeneic mouse tumor models, increased CD206+ TAM were associated with reduced tumor burden, and in patients with cutaneous melanoma, high CD206+ macrophages density correlated with improved overall survival. Here, MRC1 is linked to cutaneous melanoma.